Matthew Rizzo is a General Partner at OrbiMed. He manages the firm's royalty and credit opportunities team and has a background in pharmaceutical licensing and healthcare strategy.
What Matthew can write
OrbiMed writes $1M to $30M+ checks, larger than 83% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: OrbiMed.Career
- GSK · global commercial strategy
- Fortress Investment Group · life sciences investing
- Ikaria · responsible for pharmaceutical licensing and acquisitions
- OrbiMed · General PartnerNow
Focus
Education
Also at OrbiMed
Partners like Matthew
At firms with a similar stage, sector and check size.
Alert me when OrbiMed is active
One email when Matthew's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Matthew Rizzo?
Matthew Rizzo is a General Partner at OrbiMed. He manages the firm's royalty and credit opportunities team and has a background in pharmaceutical licensing and healthcare strategy.
How much does Matthew Rizzo invest?
Matthew Rizzo invests through OrbiMed, which writes checks of $1M to $30M+ at seed, series a, series b.
How do I pitch Matthew Rizzo?
Email [email protected], the firm's inbox for founders, and name Matthew in the subject. A warm intro from a founder OrbiMed backed works better.
What did Matthew Rizzo do before OrbiMed?
global commercial strategy at GSK; life sciences investing at Fortress Investment Group; responsible for pharmaceutical licensing and acquisitions at Ikaria.
Last updated 2026-10-15. Is this you? Ask for a correction.